JPH0136612B2 - - Google Patents
Info
- Publication number
- JPH0136612B2 JPH0136612B2 JP8841881A JP8841881A JPH0136612B2 JP H0136612 B2 JPH0136612 B2 JP H0136612B2 JP 8841881 A JP8841881 A JP 8841881A JP 8841881 A JP8841881 A JP 8841881A JP H0136612 B2 JPH0136612 B2 JP H0136612B2
- Authority
- JP
- Japan
- Prior art keywords
- compound
- formula
- group
- dye
- represented
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 150000001875 compounds Chemical class 0.000 claims description 22
- HXJUTPCZVOIRIF-UHFFFAOYSA-N sulfolane Chemical compound O=S1(=O)CCCC1 HXJUTPCZVOIRIF-UHFFFAOYSA-N 0.000 claims description 12
- 125000004432 carbon atom Chemical group C* 0.000 claims description 10
- 125000000217 alkyl group Chemical group 0.000 claims description 9
- YBBRCQOCSYXUOC-UHFFFAOYSA-N sulfuryl dichloride Chemical compound ClS(Cl)(=O)=O YBBRCQOCSYXUOC-UHFFFAOYSA-N 0.000 claims description 9
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 claims description 4
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims description 4
- 239000002253 acid Substances 0.000 claims description 4
- 229910052698 phosphorus Inorganic materials 0.000 claims description 4
- 239000011574 phosphorus Substances 0.000 claims description 4
- 229910052717 sulfur Inorganic materials 0.000 claims description 4
- 239000011593 sulfur Substances 0.000 claims description 4
- 150000001450 anions Chemical class 0.000 claims description 2
- 238000001308 synthesis method Methods 0.000 claims 1
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 18
- 239000000975 dye Substances 0.000 description 14
- 238000006243 chemical reaction Methods 0.000 description 13
- 229940125904 compound 1 Drugs 0.000 description 12
- XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 description 12
- ONBQEOIKXPHGMB-VBSBHUPXSA-N 1-[2-[(2s,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-4,6-dihydroxyphenyl]-3-(4-hydroxyphenyl)propan-1-one Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1OC1=CC(O)=CC(O)=C1C(=O)CCC1=CC=C(O)C=C1 ONBQEOIKXPHGMB-VBSBHUPXSA-N 0.000 description 11
- 229940126142 compound 16 Drugs 0.000 description 11
- 125000003118 aryl group Chemical group 0.000 description 8
- 238000000034 method Methods 0.000 description 7
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 description 6
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 6
- TVTJUIAKQFIXCE-HUKYDQBMSA-N 2-amino-9-[(2R,3S,4S,5R)-4-fluoro-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-7-prop-2-ynyl-1H-purine-6,8-dione Chemical compound NC=1NC(C=2N(C(N(C=2N=1)[C@@H]1O[C@@H]([C@H]([C@H]1O)F)CO)=O)CC#C)=O TVTJUIAKQFIXCE-HUKYDQBMSA-N 0.000 description 5
- BQXUPNKLZNSUMC-YUQWMIPFSA-N CCN(CCCCCOCC(=O)N[C@H](C(=O)N1C[C@H](O)C[C@H]1C(=O)N[C@@H](C)c1ccc(cc1)-c1scnc1C)C(C)(C)C)CCOc1ccc(cc1)C(=O)c1c(sc2cc(O)ccc12)-c1ccc(O)cc1 Chemical compound CCN(CCCCCOCC(=O)N[C@H](C(=O)N1C[C@H](O)C[C@H]1C(=O)N[C@@H](C)c1ccc(cc1)-c1scnc1C)C(C)(C)C)CCOc1ccc(cc1)C(=O)c1c(sc2cc(O)ccc12)-c1ccc(O)cc1 BQXUPNKLZNSUMC-YUQWMIPFSA-N 0.000 description 5
- -1 alkali metal salts Chemical class 0.000 description 5
- 150000001408 amides Chemical class 0.000 description 5
- 229940125851 compound 27 Drugs 0.000 description 5
- 230000002194 synthesizing effect Effects 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 4
- 230000000052 comparative effect Effects 0.000 description 4
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 4
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 description 3
- 125000001072 heteroaryl group Chemical group 0.000 description 3
- 239000005457 ice water Substances 0.000 description 3
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- 239000011541 reaction mixture Substances 0.000 description 3
- 125000001424 substituent group Chemical group 0.000 description 3
- DLFVBJFMPXGRIB-UHFFFAOYSA-N Acetamide Chemical compound CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 description 2
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 2
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical group C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- 125000003545 alkoxy group Chemical group 0.000 description 2
- 125000004390 alkyl sulfonyl group Chemical group 0.000 description 2
- 125000003277 amino group Chemical group 0.000 description 2
- 125000004397 aminosulfonyl group Chemical group NS(=O)(=O)* 0.000 description 2
- 239000000987 azo dye Substances 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 125000005521 carbonamide group Chemical group 0.000 description 2
- 238000005660 chlorination reaction Methods 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 125000004093 cyano group Chemical group *C#N 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- JBKVHLHDHHXQEQ-UHFFFAOYSA-N epsilon-caprolactam Chemical compound O=C1CCCCCN1 JBKVHLHDHHXQEQ-UHFFFAOYSA-N 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- 125000005843 halogen group Chemical group 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 125000001624 naphthyl group Chemical group 0.000 description 2
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 2
- 125000000843 phenylene group Chemical group C1(=C(C=CC=C1)*)* 0.000 description 2
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 125000003226 pyrazolyl group Chemical group 0.000 description 2
- HNJBEVLQSNELDL-UHFFFAOYSA-N pyrrolidin-2-one Chemical compound O=C1CCCN1 HNJBEVLQSNELDL-UHFFFAOYSA-N 0.000 description 2
- 125000002943 quinolinyl group Chemical group N1=C(C=CC2=CC=CC=C12)* 0.000 description 2
- 239000000376 reactant Substances 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 125000000565 sulfonamide group Chemical group 0.000 description 2
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 2
- UAOUIVVJBYDFKD-XKCDOFEDSA-N (1R,9R,10S,11R,12R,15S,18S,21R)-10,11,21-trihydroxy-8,8-dimethyl-14-methylidene-4-(prop-2-enylamino)-20-oxa-5-thia-3-azahexacyclo[9.7.2.112,15.01,9.02,6.012,18]henicosa-2(6),3-dien-13-one Chemical compound C([C@@H]1[C@@H](O)[C@@]23C(C1=C)=O)C[C@H]2[C@]12C(N=C(NCC=C)S4)=C4CC(C)(C)[C@H]1[C@H](O)[C@]3(O)OC2 UAOUIVVJBYDFKD-XKCDOFEDSA-N 0.000 description 1
- AOSZTAHDEDLTLQ-AZKQZHLXSA-N (1S,2S,4R,8S,9S,11S,12R,13S,19S)-6-[(3-chlorophenyl)methyl]-12,19-difluoro-11-hydroxy-8-(2-hydroxyacetyl)-9,13-dimethyl-6-azapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-dien-16-one Chemical compound C([C@@H]1C[C@H]2[C@H]3[C@]([C@]4(C=CC(=O)C=C4[C@@H](F)C3)C)(F)[C@@H](O)C[C@@]2([C@@]1(C1)C(=O)CO)C)N1CC1=CC=CC(Cl)=C1 AOSZTAHDEDLTLQ-AZKQZHLXSA-N 0.000 description 1
- ABJSOROVZZKJGI-OCYUSGCXSA-N (1r,2r,4r)-2-(4-bromophenyl)-n-[(4-chlorophenyl)-(2-fluoropyridin-4-yl)methyl]-4-morpholin-4-ylcyclohexane-1-carboxamide Chemical compound C1=NC(F)=CC(C(NC(=O)[C@H]2[C@@H](C[C@@H](CC2)N2CCOCC2)C=2C=CC(Br)=CC=2)C=2C=CC(Cl)=CC=2)=C1 ABJSOROVZZKJGI-OCYUSGCXSA-N 0.000 description 1
- GLGNXYJARSMNGJ-VKTIVEEGSA-N (1s,2s,3r,4r)-3-[[5-chloro-2-[(1-ethyl-6-methoxy-2-oxo-4,5-dihydro-3h-1-benzazepin-7-yl)amino]pyrimidin-4-yl]amino]bicyclo[2.2.1]hept-5-ene-2-carboxamide Chemical compound CCN1C(=O)CCCC2=C(OC)C(NC=3N=C(C(=CN=3)Cl)N[C@H]3[C@H]([C@@]4([H])C[C@@]3(C=C4)[H])C(N)=O)=CC=C21 GLGNXYJARSMNGJ-VKTIVEEGSA-N 0.000 description 1
- SZUVGFMDDVSKSI-WIFOCOSTSA-N (1s,2s,3s,5r)-1-(carboxymethyl)-3,5-bis[(4-phenoxyphenyl)methyl-propylcarbamoyl]cyclopentane-1,2-dicarboxylic acid Chemical compound O=C([C@@H]1[C@@H]([C@](CC(O)=O)([C@H](C(=O)N(CCC)CC=2C=CC(OC=3C=CC=CC=3)=CC=2)C1)C(O)=O)C(O)=O)N(CCC)CC(C=C1)=CC=C1OC1=CC=CC=C1 SZUVGFMDDVSKSI-WIFOCOSTSA-N 0.000 description 1
- GHYOCDFICYLMRF-UTIIJYGPSA-N (2S,3R)-N-[(2S)-3-(cyclopenten-1-yl)-1-[(2R)-2-methyloxiran-2-yl]-1-oxopropan-2-yl]-3-hydroxy-3-(4-methoxyphenyl)-2-[[(2S)-2-[(2-morpholin-4-ylacetyl)amino]propanoyl]amino]propanamide Chemical compound C1(=CCCC1)C[C@@H](C(=O)[C@@]1(OC1)C)NC([C@H]([C@@H](C1=CC=C(C=C1)OC)O)NC([C@H](C)NC(CN1CCOCC1)=O)=O)=O GHYOCDFICYLMRF-UTIIJYGPSA-N 0.000 description 1
- STBLNCCBQMHSRC-BATDWUPUSA-N (2s)-n-[(3s,4s)-5-acetyl-7-cyano-4-methyl-1-[(2-methylnaphthalen-1-yl)methyl]-2-oxo-3,4-dihydro-1,5-benzodiazepin-3-yl]-2-(methylamino)propanamide Chemical compound O=C1[C@@H](NC(=O)[C@H](C)NC)[C@H](C)N(C(C)=O)C2=CC(C#N)=CC=C2N1CC1=C(C)C=CC2=CC=CC=C12 STBLNCCBQMHSRC-BATDWUPUSA-N 0.000 description 1
- QFLWZFQWSBQYPS-AWRAUJHKSA-N (3S)-3-[[(2S)-2-[[(2S)-2-[5-[(3aS,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoylamino]-3-methylbutanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-4-[1-bis(4-chlorophenoxy)phosphorylbutylamino]-4-oxobutanoic acid Chemical compound CCCC(NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)CCCCC1SC[C@@H]2NC(=O)N[C@H]12)C(C)C)P(=O)(Oc1ccc(Cl)cc1)Oc1ccc(Cl)cc1 QFLWZFQWSBQYPS-AWRAUJHKSA-N 0.000 description 1
- IWZSHWBGHQBIML-ZGGLMWTQSA-N (3S,8S,10R,13S,14S,17S)-17-isoquinolin-7-yl-N,N,10,13-tetramethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-amine Chemical compound CN(C)[C@H]1CC[C@]2(C)C3CC[C@@]4(C)[C@@H](CC[C@@H]4c4ccc5ccncc5c4)[C@@H]3CC=C2C1 IWZSHWBGHQBIML-ZGGLMWTQSA-N 0.000 description 1
- KQZLRWGGWXJPOS-NLFPWZOASA-N 1-[(1R)-1-(2,4-dichlorophenyl)ethyl]-6-[(4S,5R)-4-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]-5-methylcyclohexen-1-yl]pyrazolo[3,4-b]pyrazine-3-carbonitrile Chemical compound ClC1=C(C=CC(=C1)Cl)[C@@H](C)N1N=C(C=2C1=NC(=CN=2)C1=CC[C@@H]([C@@H](C1)C)N1[C@@H](CCC1)CO)C#N KQZLRWGGWXJPOS-NLFPWZOASA-N 0.000 description 1
- WZZBNLYBHUDSHF-DHLKQENFSA-N 1-[(3s,4s)-4-[8-(2-chloro-4-pyrimidin-2-yloxyphenyl)-7-fluoro-2-methylimidazo[4,5-c]quinolin-1-yl]-3-fluoropiperidin-1-yl]-2-hydroxyethanone Chemical compound CC1=NC2=CN=C3C=C(F)C(C=4C(=CC(OC=5N=CC=CN=5)=CC=4)Cl)=CC3=C2N1[C@H]1CCN(C(=O)CO)C[C@@H]1F WZZBNLYBHUDSHF-DHLKQENFSA-N 0.000 description 1
- UNILWMWFPHPYOR-KXEYIPSPSA-M 1-[6-[2-[3-[3-[3-[2-[2-[3-[[2-[2-[[(2r)-1-[[2-[[(2r)-1-[3-[2-[2-[3-[[2-(2-amino-2-oxoethoxy)acetyl]amino]propoxy]ethoxy]ethoxy]propylamino]-3-hydroxy-1-oxopropan-2-yl]amino]-2-oxoethyl]amino]-3-[(2r)-2,3-di(hexadecanoyloxy)propyl]sulfanyl-1-oxopropan-2-yl Chemical compound O=C1C(SCCC(=O)NCCCOCCOCCOCCCNC(=O)COCC(=O)N[C@@H](CSC[C@@H](COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC)C(=O)NCC(=O)N[C@H](CO)C(=O)NCCCOCCOCCOCCCNC(=O)COCC(N)=O)CC(=O)N1CCNC(=O)CCCCCN\1C2=CC=C(S([O-])(=O)=O)C=C2CC/1=C/C=C/C=C/C1=[N+](CC)C2=CC=C(S([O-])(=O)=O)C=C2C1 UNILWMWFPHPYOR-KXEYIPSPSA-M 0.000 description 1
- YSUIQYOGTINQIN-UZFYAQMZSA-N 2-amino-9-[(1S,6R,8R,9S,10R,15R,17R,18R)-8-(6-aminopurin-9-yl)-9,18-difluoro-3,12-dihydroxy-3,12-bis(sulfanylidene)-2,4,7,11,13,16-hexaoxa-3lambda5,12lambda5-diphosphatricyclo[13.2.1.06,10]octadecan-17-yl]-1H-purin-6-one Chemical compound NC1=NC2=C(N=CN2[C@@H]2O[C@@H]3COP(S)(=O)O[C@@H]4[C@@H](COP(S)(=O)O[C@@H]2[C@@H]3F)O[C@H]([C@H]4F)N2C=NC3=C2N=CN=C3N)C(=O)N1 YSUIQYOGTINQIN-UZFYAQMZSA-N 0.000 description 1
- QBWKPGNFQQJGFY-QLFBSQMISA-N 3-[(1r)-1-[(2r,6s)-2,6-dimethylmorpholin-4-yl]ethyl]-n-[6-methyl-3-(1h-pyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]-1,2-thiazol-5-amine Chemical compound N1([C@H](C)C2=NSC(NC=3C4=NC=C(N4C=C(C)N=3)C3=CNN=C3)=C2)C[C@H](C)O[C@H](C)C1 QBWKPGNFQQJGFY-QLFBSQMISA-N 0.000 description 1
- ISMDILRWKSYCOD-GNKBHMEESA-N C(C1=CC=CC=C1)[C@@H]1NC(OCCCCCCCCCCCNC([C@@H](NC(C[C@@H]1O)=O)C(C)C)=O)=O Chemical compound C(C1=CC=CC=C1)[C@@H]1NC(OCCCCCCCCCCCNC([C@@H](NC(C[C@@H]1O)=O)C(C)C)=O)=O ISMDILRWKSYCOD-GNKBHMEESA-N 0.000 description 1
- KCBAMQOKOLXLOX-BSZYMOERSA-N CC1=C(SC=N1)C2=CC=C(C=C2)[C@H](C)NC(=O)[C@@H]3C[C@H](CN3C(=O)[C@H](C(C)(C)C)NC(=O)CCCCCCCCCCNCCCONC(=O)C4=C(C(=C(C=C4)F)F)NC5=C(C=C(C=C5)I)F)O Chemical compound CC1=C(SC=N1)C2=CC=C(C=C2)[C@H](C)NC(=O)[C@@H]3C[C@H](CN3C(=O)[C@H](C(C)(C)C)NC(=O)CCCCCCCCCCNCCCONC(=O)C4=C(C(=C(C=C4)F)F)NC5=C(C=C(C=C5)I)F)O KCBAMQOKOLXLOX-BSZYMOERSA-N 0.000 description 1
- 229940126657 Compound 17 Drugs 0.000 description 1
- 229940126639 Compound 33 Drugs 0.000 description 1
- OPFJDXRVMFKJJO-ZHHKINOHSA-N N-{[3-(2-benzamido-4-methyl-1,3-thiazol-5-yl)-pyrazol-5-yl]carbonyl}-G-dR-G-dD-dD-dD-NH2 Chemical compound S1C(C=2NN=C(C=2)C(=O)NCC(=O)N[C@H](CCCN=C(N)N)C(=O)NCC(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CC(O)=O)C(N)=O)=C(C)N=C1NC(=O)C1=CC=CC=C1 OPFJDXRVMFKJJO-ZHHKINOHSA-N 0.000 description 1
- LJOOWESTVASNOG-UFJKPHDISA-N [(1s,3r,4ar,7s,8s,8as)-3-hydroxy-8-[2-[(4r)-4-hydroxy-6-oxooxan-2-yl]ethyl]-7-methyl-1,2,3,4,4a,7,8,8a-octahydronaphthalen-1-yl] (2s)-2-methylbutanoate Chemical compound C([C@H]1[C@@H](C)C=C[C@H]2C[C@@H](O)C[C@@H]([C@H]12)OC(=O)[C@@H](C)CC)CC1C[C@@H](O)CC(=O)O1 LJOOWESTVASNOG-UFJKPHDISA-N 0.000 description 1
- LNUFLCYMSVYYNW-ZPJMAFJPSA-N [(2r,3r,4s,5r,6r)-2-[(2r,3r,4s,5r,6r)-6-[(2r,3r,4s,5r,6r)-6-[(2r,3r,4s,5r,6r)-6-[[(3s,5s,8r,9s,10s,13r,14s,17r)-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-3-yl]oxy]-4,5-disulfo Chemical compound O([C@@H]1[C@@H](COS(O)(=O)=O)O[C@@H]([C@@H]([C@H]1OS(O)(=O)=O)OS(O)(=O)=O)O[C@@H]1[C@@H](COS(O)(=O)=O)O[C@@H]([C@@H]([C@H]1OS(O)(=O)=O)OS(O)(=O)=O)O[C@@H]1[C@@H](COS(O)(=O)=O)O[C@H]([C@@H]([C@H]1OS(O)(=O)=O)OS(O)(=O)=O)O[C@@H]1C[C@@H]2CC[C@H]3[C@@H]4CC[C@@H]([C@]4(CC[C@@H]3[C@@]2(C)CC1)C)[C@H](C)CCCC(C)C)[C@H]1O[C@H](COS(O)(=O)=O)[C@@H](OS(O)(=O)=O)[C@H](OS(O)(=O)=O)[C@H]1OS(O)(=O)=O LNUFLCYMSVYYNW-ZPJMAFJPSA-N 0.000 description 1
- SMNRFWMNPDABKZ-WVALLCKVSA-N [[(2R,3S,4R,5S)-5-(2,6-dioxo-3H-pyridin-3-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [[[(2R,3S,4S,5R,6R)-4-fluoro-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl] hydrogen phosphate Chemical compound OC[C@H]1O[C@H](OP(O)(=O)OP(O)(=O)OP(O)(=O)OP(O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)C2C=CC(=O)NC2=O)[C@H](O)[C@@H](F)[C@@H]1O SMNRFWMNPDABKZ-WVALLCKVSA-N 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 239000001000 anthraquinone dye Substances 0.000 description 1
- XRWSZZJLZRKHHD-WVWIJVSJSA-N asunaprevir Chemical compound O=C([C@@H]1C[C@H](CN1C(=O)[C@@H](NC(=O)OC(C)(C)C)C(C)(C)C)OC1=NC=C(C2=CC=C(Cl)C=C21)OC)N[C@]1(C(=O)NS(=O)(=O)C2CC2)C[C@H]1C=C XRWSZZJLZRKHHD-WVWIJVSJSA-N 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 150000001805 chlorine compounds Chemical class 0.000 description 1
- 238000004532 chromating Methods 0.000 description 1
- 229940125773 compound 10 Drugs 0.000 description 1
- 229940125797 compound 12 Drugs 0.000 description 1
- 229940126543 compound 14 Drugs 0.000 description 1
- 229940125758 compound 15 Drugs 0.000 description 1
- 229940125782 compound 2 Drugs 0.000 description 1
- 229940125810 compound 20 Drugs 0.000 description 1
- 229940126086 compound 21 Drugs 0.000 description 1
- 229940126208 compound 22 Drugs 0.000 description 1
- 229940125833 compound 23 Drugs 0.000 description 1
- 229940125961 compound 24 Drugs 0.000 description 1
- 229940125846 compound 25 Drugs 0.000 description 1
- 229940127204 compound 29 Drugs 0.000 description 1
- 229940126214 compound 3 Drugs 0.000 description 1
- 229940125877 compound 31 Drugs 0.000 description 1
- 229940125878 compound 36 Drugs 0.000 description 1
- 229940125898 compound 5 Drugs 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- XLZCIXFPTHCUFB-UHFFFAOYSA-N dmf pocl3 Chemical compound CN(C)C=O.ClP(Cl)(Cl)=O XLZCIXFPTHCUFB-UHFFFAOYSA-N 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- JAXFJECJQZDFJS-XHEPKHHKSA-N gtpl8555 Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@@H]1C(=O)N[C@H](B1O[C@@]2(C)[C@H]3C[C@H](C3(C)C)C[C@H]2O1)CCC1=CC=C(F)C=C1 JAXFJECJQZDFJS-XHEPKHHKSA-N 0.000 description 1
- 125000005842 heteroatom Chemical group 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 239000000543 intermediate Substances 0.000 description 1
- ZLVXBBHTMQJRSX-VMGNSXQWSA-N jdtic Chemical compound C1([C@]2(C)CCN(C[C@@H]2C)C[C@H](C(C)C)NC(=O)[C@@H]2NCC3=CC(O)=CC=C3C2)=CC=CC(O)=C1 ZLVXBBHTMQJRSX-VMGNSXQWSA-N 0.000 description 1
- 239000000434 metal complex dye Substances 0.000 description 1
- VSEAAEQOQBMPQF-UHFFFAOYSA-N morpholin-3-one Chemical compound O=C1COCCN1 VSEAAEQOQBMPQF-UHFFFAOYSA-N 0.000 description 1
- FDRVTDDJHPPAGK-UHFFFAOYSA-N n,n-dimethylformamide;thionyl dichloride Chemical compound ClS(Cl)=O.CN(C)C=O FDRVTDDJHPPAGK-UHFFFAOYSA-N 0.000 description 1
- 150000007530 organic bases Chemical class 0.000 description 1
- 150000002923 oximes Chemical class 0.000 description 1
- 125000001820 oxy group Chemical group [*:1]O[*:2] 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- UHZYTMXLRWXGPK-UHFFFAOYSA-N phosphorus pentachloride Chemical compound ClP(Cl)(Cl)(Cl)Cl UHZYTMXLRWXGPK-UHFFFAOYSA-N 0.000 description 1
- 239000001007 phthalocyanine dye Substances 0.000 description 1
- XUWHAWMETYGRKB-UHFFFAOYSA-N piperidin-2-one Chemical compound O=C1CCCCN1 XUWHAWMETYGRKB-UHFFFAOYSA-N 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 239000000779 smoke Substances 0.000 description 1
- XTHPWXDJESJLNJ-UHFFFAOYSA-N sulfurochloridic acid Chemical compound OS(Cl)(=O)=O XTHPWXDJESJLNJ-UHFFFAOYSA-N 0.000 description 1
- 125000003258 trimethylene group Chemical group [H]C([H])([*:2])C([H])([H])C([H])([H])[*:1] 0.000 description 1
Description
本発明は色素残基をもつスルホニルクロリドの
合成法に関する。色素残基をもつスルホニルクロ
リドは、拡散転写法カラー写真に用いる色素放出
化合物の合成中間体として重要である。
従来、色素残基をもつスルホニルクロリドの合
成反応剤として五塩化リン〔Helv.Chim.Acta38、
1329(1955)〕およびクロルスルホン酸〔米国特許
3929760号〕が知られていたが、いずれも発煙性
であり取扱いが困難で工業的規模の合成には適さ
ない。また、塩化チオニル−N,N−ジメチルホ
ルムアミド〔Helv.Chim.Acta42、1653(1959)〕
およびオキシ塩化リン−N,N−ジメチルホルム
アミド〔米国特許4013633(1977)〕がクロム化剤
として知られているが、官能基選択性
(chemoselectivity)に乏しいことがその後の研
究で明らかになつた。オキシ塩化リン−N,N−
ジメチルアセトアミドを用いるクロル化が報告さ
れているが〔特開昭54−161332〕、収率の点でな
お一層の改良が望まれている。
本発明の目的は第1に収率の高いスルホニルク
ロリドの合成法を提供することにあり、第2の緩
和な条件でしかも簡便な操作でスルホニルクロリ
ドを合成することができる方法を提供することに
あり、第3に官能基選択的なスルホニルクロリド
の合成法を提供することにある。
本発明者は、上記目的に鑑み鋭意研究を重ねた
結果、遂に上記目的を達成する本発明をなすに至
つた。
すなわち、本発明は、下記一般式()で表わ
される色素残基をもつスルホン酸を、スルホラン
の存在下に一般式()で表わされる化合物と反
応させることを特徴とする下記一般式()で表
わされるスルホニルクロリドの合成法である。
ただし、Dyeは色素残基を表わし;R1は炭素数
1〜23のアルキル基を表わし;R2およびR3は同
じでも異つていてもよく、炭素数1〜24のアルキ
ル基を表わす。R1とR2;R2とR3は相互に結合し
て環を形成していてもよい。上記のアルキル基は
置換基を有してもよいが、好ましくは置換基を有
していないものである。Yはリンまたはイオウを
含む酸のアニオンである。なお〔〕で表わされ
る化合物は、対応する塩(たとえばアルカリ金属
塩、有機塩基の塩)なども含むものとする。
Dyeで表わされる色素残基の例は、アゾ色素、
アントラキノン色素、アゾメチン色素、フタロシ
アニン色素、金属錯体色素などがあげられる。な
かんずく、本発明の方法の特色はDyeがアゾ色素
残基の場合に発揮される。すなわち好ましい態様
においては、()および()であらわされる
化合物がそれぞれ次の式()および()で表
わされる場合である。
A−N=N−B−(L)o―SO3H 〔〕
A−N=N−B−(L)o―SO2Cl 〔〕
ただし、Aは芳香族基あるいはヘテロ芳香族基
を表わし、Bは芳香族基あるいはヘテロ芳香族基
を表わす。Lは二価の芳香族基あるいは脂肪族基
を表わし、nは0または1である。
AまたはBで表わされる芳香族基の例として
は、フエニル基、またはナフタレン基を挙げるこ
とができる。これらのフエニル基またはナフタレ
ン基は、ヒドロキシル基、アルキル基、フエニル
基、アルコキシ基、カルボンアミド基、スルホン
アミド基、カルバモイル基、スルフアモイル基、
アミノ基、シアノ基、ニトロ基、アルキルスルホ
ニル基、芳香族スルホニル基、ハロゲン原子、ト
リフルオロメチル基などで置換されていてもよ
い。
AまたはBで表わされるヘテロ芳香環の例とし
ては、ピラゾール基、ピリジン基、キノリン基な
どが挙げられる。これらのピラゾール基、ピリジ
ン基またはキノリン基などは、ヒドロキシル基、
アルキル基、フエニル基、アルコキシ基、カルボ
ンアミド基、スルホンアミド基、カルボモイル
基、スルフアモイル基、アミノ基、シアノ基、ニ
トロ基、アルキルスルホニル基、芳香族スルホニ
ル基、ハロゲン原子、トリフルオロメチル基など
で置換されていてもよい。
Lで表わされる二価の芳香族基としては、フエ
ニレン基をあげることができる。このフエニレン
基は上記Aで表わされる芳香族基の場合にあげた
置換基で置換されていてもよい。
式〔〕で表わされる化合物は、米国特許
3954476;同3932380;同3931144;同3942987;同
4013635;同4013633;同4135929;同4076529;英
国特許2026711A;同2027220A;同2029852A;同
2010883A;西独特許出願(OLS)2630999;同
2847371;リサーチ・デスクロジヤ17630(1978);
同16475(1977)などに記載がある化合物を含む。
R1のアルキル基は直鎖でも分枝してもよく、
炭素数は1〜23好ましくは1〜17、さらに好まし
くは1〜4であり、例えば、メチル基、エチル
基、プロピル基、イソプロピル基、ブチル基など
があげられる。
R2またはR3のアルキル基は直鎖でも分枝でも
よく炭素数1〜24、好ましくは1〜18さらに好ま
しくは1〜4であり、例えばメチル基、エチル
基、プロピル基、イソプロピル基、ブチル基など
があげられる。
R1とR2、R2とR3が相互に結合して環状になる
ときには該環中に1〜2個のヘテロ原子(酸素、
窒素、硫黄)を含んでもよい。R1とR2が結合し
た場合にはアミド結合が環の一部を形成するの
で、例えばモルホリン−3−オン、ピロリドン、
カプロラクタム、ピペリドン、ピロリジノンなど
のオキシ基(=o)を持つ環が構成される。一方
R2とR3が結合した場合にはアミド窒素が環の一
員となり、例えばモルホリン、ピロリジン、ピペ
リジンなどの環が構成される。
入手が容易で反応後の処理が簡単な点では、
R1、R2、R3がすべてメチル基である場合;およ
びR1とR2が結合してトリメチレン基となりかつ
R3がメチル基である場合が好ましく、なかでも
前者がより好ましい。
Y
としては、
OPOCl2、
OSOClなどが好
ましい。式()で表わされる化合物は、好まし
くは式()で表わされるアミドと、式()で
表わされる酸クロリドから生成せしめる。
(ただし、R1、R2、R3の記号は式()と同義。
Y1はリンまたはイオウを含む酸の残基である。)
ここでY−HとY1−OHは同じ化合物を表わす
ことを付言する。
本発明で合成されるスルホニルクロリドの具体
例を示せば次の通りである。
化合物1
The present invention relates to a method for synthesizing sulfonyl chloride having a dye residue. Sulfonyl chlorides with dye residues are important as intermediates for the synthesis of dye-releasing compounds used in diffusion transfer color photography. Conventionally, phosphorus pentachloride [Helv.Chim.Acta 38 ,
1329 (1955)] and chlorsulfonic acid [U.S.
No. 3929760], but all of them emit smoke and are difficult to handle, making them unsuitable for industrial-scale synthesis. Also, thionyl chloride-N,N-dimethylformamide [Helv.Chim.Acta 42 , 1653 (1959)]
Although phosphorus oxychloride-N,N-dimethylformamide [US Pat. No. 4,013,633 (1977)] is known as a chromating agent, subsequent research has revealed that it has poor chemoselectivity. Phosphorus oxychloride-N,N-
Although chlorination using dimethylacetamide has been reported [JP-A-54-161332], further improvement in yield is desired. The first object of the present invention is to provide a method for synthesizing sulfonyl chloride with a high yield, and the second object is to provide a method for synthesizing sulfonyl chloride under mild conditions and with simple operations. The third object is to provide a functional group-selective method for synthesizing sulfonyl chloride. The present inventor has conducted intensive research in view of the above object, and as a result, has finally achieved the present invention that achieves the above object. That is, the present invention is characterized in that a sulfonic acid having a dye residue represented by the following general formula () is reacted with a compound represented by the general formula () in the presence of sulfolane. This is a method for synthesizing the sulfonyl chloride shown below. However, Dye represents a dye residue; R 1 represents an alkyl group having 1 to 23 carbon atoms; R 2 and R 3 may be the same or different and represent an alkyl group having 1 to 24 carbon atoms. R 1 and R 2 ; R 2 and R 3 may be bonded to each other to form a ring. The above alkyl group may have a substituent, but preferably has no substituent. Y is an anion of an acid containing phosphorus or sulfur. Note that the compounds represented by [ ] also include corresponding salts (for example, alkali metal salts and salts of organic bases). Examples of dye residues represented by Dye are azo dye,
Examples include anthraquinone dyes, azomethine dyes, phthalocyanine dyes, and metal complex dyes. Above all, the special features of the method of the present invention are exhibited when the Dye is an azo dye residue. That is, in a preferred embodiment, the compounds represented by () and () are represented by the following formulas () and (), respectively. A-N=N-B-(L) o ―SO 3 H [] A-N=N-B-(L) o ―SO 2 Cl [] However, A represents an aromatic group or a heteroaromatic group. , B represents an aromatic group or a heteroaromatic group. L represents a divalent aromatic group or aliphatic group, and n is 0 or 1. Examples of the aromatic group represented by A or B include a phenyl group or a naphthalene group. These phenyl groups or naphthalene groups include hydroxyl groups, alkyl groups, phenyl groups, alkoxy groups, carbonamide groups, sulfonamide groups, carbamoyl groups, sulfamoyl groups,
It may be substituted with an amino group, a cyano group, a nitro group, an alkylsulfonyl group, an aromatic sulfonyl group, a halogen atom, a trifluoromethyl group, or the like. Examples of the heteroaromatic ring represented by A or B include a pyrazole group, a pyridine group, a quinoline group, and the like. These pyrazole groups, pyridine groups, quinoline groups, etc. are hydroxyl groups,
Alkyl group, phenyl group, alkoxy group, carbonamide group, sulfonamide group, carbomoyl group, sulfamoyl group, amino group, cyano group, nitro group, alkylsulfonyl group, aromatic sulfonyl group, halogen atom, trifluoromethyl group, etc. May be replaced. The divalent aromatic group represented by L includes a phenylene group. This phenylene group may be substituted with the substituents listed for the aromatic group represented by A above. The compound represented by the formula [] is a compound represented by the U.S. patent
3954476; 3932380; 3931144; 3942987;
4013635; 4013633; 4135929; 4076529; British patent 2026711A; 2027220A; 2029852A;
2010883A; West German patent application (OLS) 2630999;
2847371; Research Disclosure 17630 (1978);
Contains compounds described in 16475 (1977), etc. The alkyl group of R 1 may be straight chain or branched,
It has 1 to 23 carbon atoms, preferably 1 to 17 carbon atoms, and more preferably 1 to 4 carbon atoms, and includes, for example, a methyl group, an ethyl group, a propyl group, an isopropyl group, a butyl group, and the like. The alkyl group of R 2 or R 3 may be linear or branched and has 1 to 24 carbon atoms, preferably 1 to 18 carbon atoms, and more preferably 1 to 4 carbon atoms, such as methyl group, ethyl group, propyl group, isopropyl group, butyl group. Examples include bases. When R 1 and R 2 or R 2 and R 3 are bonded to each other to form a ring, 1 to 2 heteroatoms (oxygen,
(nitrogen, sulfur). When R 1 and R 2 are combined, the amide bond forms part of the ring, so for example, morpholin-3-one, pyrrolidone,
A ring with an oxy group (=o) such as caprolactam, piperidone, and pyrrolidinone is formed. on the other hand
When R 2 and R 3 are combined, the amide nitrogen becomes a member of the ring, forming a ring such as morpholine, pyrrolidine, piperidine, etc. It is easy to obtain and easy to process after reaction.
When R 1 , R 2 and R 3 are all methyl groups; and when R 1 and R 2 combine to form a trimethylene group and
It is preferable that R 3 is a methyl group, and the former is particularly preferable. As Y, OPOCl2 , OSOCl, etc. are preferable. The compound represented by formula () is preferably produced from an amide represented by formula () and an acid chloride represented by formula (). (However, the symbols R 1 , R 2 , and R 3 have the same meaning as in formula ().
Y 1 is an acid residue containing phosphorus or sulfur. ) It should be added here that Y-H and Y 1 -OH represent the same compound. Specific examples of the sulfonyl chloride synthesized in the present invention are as follows. Compound 1
【式】ただし[Formula] However
【式】
化合物2
化合物1の式において
[Formula] Compound 2 In the formula of Compound 1
【式】
化合物3
化合物1の式において
[Formula] Compound 3 In the formula of Compound 1
【式】
化合物4
化合物1の式において
[Formula] Compound 4 In the formula of Compound 1
【式】
化合物5
化合物1の式において
[Formula] Compound 5 In the formula of Compound 1
【式】
化合物6
化合物1の式において
[Formula] Compound 6 In the formula of Compound 1
【式】
化合物7
化合物1の式において
[Formula] Compound 7 In the formula of Compound 1
【式】
化合物8
化合物1の式において
[Formula] Compound 8 In the formula of Compound 1
【式】
化合物9
化合物1の式において
[Formula] Compound 9 In the formula of Compound 1
【式】
化合物10
化合物1の式において
[Formula] Compound 10 In the formula of compound 1
【式】
化合物11
化合物1の式において
[Formula] Compound 11 In the formula of compound 1
【式】
化合物12
化合物1の式において
[Formula] Compound 12 In the formula of compound 1
【式】 化合物13 化合物14[Formula] Compound 13 compound 14
【式】 化合物15【formula】 compound 15
【式】
化合物16
ただしR4=CH3、R5=H
化合物17
化合物16の式で
R4=−C2H5 R5=H
化合物18
化合物16の式で
R4=−CH(CH3)2 R5=H
化合物19
化合物16の式で
R4=−C2H5 R5=−C2H5
化合物20
化合物16の式で
R4=−C3H7−(n) R5=−C3H7−(n)
化合物21
化合物16の式で
R4、R5=−(CH2)4−
化合物22
化合物16の式で
R4=−C6H5 R5=H
化合物23
化合物16の式で
R4=CH3 R5=CH3
化合物24
化合物16の式で
R4=C4H9(n) R5=C4H9(n)
化合物25
化合物16の式で
R4=C4H9(t) R5=H
化合物26
化合物16の式で
R4=R5=−CH(CH3)2
化合物27
ただし、R4=CH3、R5=H
化合物28
化合物27の式で
R4=C2H5、R5=H
化合物29
化合物27の式で
R4=CH(CH3)2 R5=H
化合物30
化合物27の式で
R4=R5=C2H5
化合物31
化合物27の式で
R4=C4H9(t) R5=H
化合物32
ただし、R4=CH3、R5=H
化合物33
化合物32の式で
R4=C2H5、R5=H
化合物34
化合物32の式で
R4=CH(CH3)2、R5=H
化合物35
化合物32の式で
R4=R5=C2H5
化合物36
化合物32の式で R4=C4H9(t)、R5=H
本発明の合成法は、前記色素スルホン酸()
をスルホラン中に溶解または懸濁し、反応剤
()を反応させることによつて実施される。反
応剤()は、アミド()と酸クロリド()
からin situに生成させることが一般的である。
この場合、色素スルホン酸()、アミド()
およびスルホラン(アセトニトリルなどの反応に
影響を与えない溶媒を加えてもよい。)を混合し、
これに酸クロリド()を滴下するという簡便な
操作で実現される。
また酸クロリド()は反応に影響与えない溶
媒で希釈して滴下してもよく、あるいはそのまま
(希釈せずに)滴下してもよい。
本発明におけるアミド()の使用量は上記し
た理由により上限がなく、基本的には触媒量以
上、より具体的には色素スルホン酸()1モル
に対して約0.001モル以上、好ましくは約0.01モ
ル以上の範囲で使用する。特に好ましくは0.1モ
ル〜5モルの範囲がよい。
本発明における酸クロリド()の使用量は、
一般的には色素スルホン酸()1モル当り約
0.3モル〜約20モル、好ましくは約1モル〜約5
モルの範囲で使用する。
本発明に用いるスルホランは、本発明のクロル
化反応の収率を向上させるために顕著な効果をも
つている。スルホランは溶媒として用いるのがよ
く、色素スルホン酸1モルに対し約50ml〜50、
好ましくは100ml〜10、より好ましくは500ml〜
5の範囲で使用する。
前記した本発明の反応は速やかに進行するの
で、反応温度に特別な限定はないが、約10℃〜約
200℃、好ましくは約10℃〜約100℃、特に好まし
くは約30℃〜約60℃の範囲に設定する。反応は普
通常圧下で行うが、低度の加圧又は減圧下でも差
し支えない。
オキシ塩化リンの滴下時間は反応温度、原料の
オキシムの種類、反応規模等に基づいて適宜に決
定することができるが、通常約5分〜約3時間の
範囲で設定できる。オキシ塩化リンの滴下が終つ
た後更に30分〜2時間、上記温度に保持しておい
て反応を完結させてもよい。
反応終了後は、通常は放冷後氷水に注いで析出
した結晶を取する。必要ならば適当な溶媒例え
ばベンゼン、アセトニトリル等の中で再結晶を行
い目的のスルホニルクロリド()を得る。
さらに詳細な合成操作を示すため、以下に実施
例および比較例を挙げる。
実施例 1
3−シアノ−4−(2−メトキシ−5−スルホ
フエニルヒドラゾン)−1−フエニル−5−ピラ
ゾロンナトリウム塩4.21gをスルホラン10mlおよ
びアセトニトリル10mlの混合液に懸濁し、N,N
−ジメチルアセトアミド3.6mlを加えた。これに、
オキシ塩化リン3.6mlを40℃以下で加えた。反応
混合物を50〜55℃で1.5時間撹拌した。冷却後、
氷水にあけ析出した結晶を取した。化合物8の
収量4.06g(97%)。mp.235〜236℃(分解)。
比較例 1
実施例1と同一の化合物を用い、スルホランの
ない条件で反応を行つた。3−シアノ−4−(2
−メトキシ−5−スルホフエニルヒドラゾノ)−
1−フエニル−5−ピラゾロンナトリウム塩4.21
gをアセトニトリル40mlに懸濁し、N,N−ジメ
チルアセトアミド3.6mlついでオキシ塩化リン3.6
mlを加えた。50〜55℃で1.5時間撹拌したのち、
実施例1と同様の後処理を行つたところ、化合物
8が収量3.40g(81%)で得られた。
両者の実験を比較すると、スルホランの存在下
では大幅な収率向上が認められることがわかる。
実施例 2
3−(N−メチルスルフアモイル)−4−(2−
メチル−4−スルホフエニルヒドラゾノ)−1−
フエニル−5−ピラゾロンナトリウム塩4.37gを
スルホラン20ml、およびアセトニトリル30mlの混
合液に懸濁し、N,N−ジメチルアセトアミド
3.6ml、ついでオキシ塩化リンを加えた。反応混
合物を50〜55℃で1.5時間撹拌した。反応混合物
を冷却後氷水にあけて、析出した化合物4を取
した。収量3.95g(91%)。mp.217〜218℃(分
解)。
比較例 2
実施例2と同一の化合物を用い、スルホランの
ない条件で反応を行つた。3−(N−メチルスル
フアモイル)−4−(2−メチル−4−スルホフエ
ニルヒドラゾノ)−1−フエニル−5−ピラゾロ
ンナトリウム塩4.37gをアセトニトリル40mlに懸
濁し、N,N−ジメチルアセトアミド3.6mlつい
でオキシ塩化リンを加えた。50〜55℃で1.5時間
撹拌したのち、実施例2と同様の後処理を行つた
ところ、化合物4が収量3.04g(70%)で得られ
た。
実施例2と比較例2を比較すると、スルホラン
の存在下では大幅な収率向上が認められることが
わかる。[Formula] Compound 16 However, R 4 = CH 3 , R 5 = H Compound 17 In the formula of compound 16 R 4 = -C 2 H 5 R 5 = H Compound 18 In the formula of compound 16 R 4 = -CH (CH 3 ) 2 R 5 = H Compound 19 In the formula of compound 16 R 4 = -C 2 H 5 R 5 = -C 2 H 5 Compound 20 In the formula of compound 16 R 4 = -C 3 H 7 -(n) R 5 = -C 3 H 7 -(n) Compound 21 In the formula of compound 16 R 4 , R 5 = -(CH 2 ) 4 - Compound 22 In the formula of compound 16 R 4 = -C 6 H 5 R 5 =H Compound 23 In the formula of compound 16 R 4 = CH 3 R 5 = CH 3 Compound 24 In the formula of compound 16 R 4 = C 4 H 9 (n) R 5 = C 4 H 9 (n) Compound 25 In the formula of compound 16 R 4 = C 4 H 9 (t) R 5 = H Compound 26 In the formula of compound 16 R 4 = R 5 = -CH(CH 3 ) 2 Compound 27 However, R 4 = CH 3 , R 5 = H Compound 28 In the formula of compound 27 R 4 = C 2 H 5 , R 5 = H Compound 29 In the formula of compound 27 R 4 = CH(CH 3 ) 2 R 5 = H Compound 30 In the formula of compound 27, R 4 = R 5 = C 2 H 5 Compound 31 In the formula of compound 27, R 4 = C 4 H 9 (t) R 5 = H Compound 32 However, R 4 = CH 3 , R 5 = H Compound 33 In the formula of Compound 32, R 4 = C 2 H 5 , R 5 = H Compound 34 In the formula of Compound 32, R 4 = CH(CH 3 ) 2 , R 5 =H Compound 35 In the formula of Compound 32, R 4 = R 5 = C 2 H 5 Compound 36 In the formula of Compound 32, R 4 = C 4 H 9 (t), R 5 = H Sulfonic acid()
is dissolved or suspended in sulfolane and reacted with the reactant (). Reactants () are amides () and acid chlorides ()
It is common to generate it in situ from
In this case, the dye sulfonic acid (), amide ()
and sulfolane (a solvent such as acetonitrile that does not affect the reaction may be added),
This can be achieved by a simple operation of dropping acid chloride () onto this. Further, the acid chloride (2) may be added dropwise after being diluted with a solvent that does not affect the reaction, or may be added dropwise as is (without dilution). The amount of amide () to be used in the present invention has no upper limit for the reasons mentioned above, and is basically a catalytic amount or more, more specifically about 0.001 mol or more per 1 mol of dye sulfonic acid (), preferably about 0.01 mol or more. Use in a molar or higher range. Particularly preferably, the amount is in the range of 0.1 mol to 5 mol. The amount of acid chloride () used in the present invention is:
Generally, about 1 mole of dye sulfonic acid ()
0.3 moles to about 20 moles, preferably about 1 mole to about 5 moles
Use in molar range. The sulfolane used in the present invention has a remarkable effect on improving the yield of the chlorination reaction of the present invention. Sulfolane is best used as a solvent, about 50ml to 50% per mole of dye sulfonic acid.
Preferably 100ml~10, more preferably 500ml~
Use within the range of 5. Since the reaction of the present invention described above proceeds rapidly, there is no particular limitation on the reaction temperature, but the reaction temperature is about 10°C to about 10°C.
The temperature is set at 200°C, preferably about 10°C to about 100°C, particularly preferably about 30°C to about 60°C. The reaction is usually carried out under normal pressure, but may also be carried out under low pressure or reduced pressure. The time for dropping phosphorus oxychloride can be appropriately determined based on the reaction temperature, the type of oxime used as a raw material, the scale of the reaction, etc., and can usually be set within a range of about 5 minutes to about 3 hours. After the dropwise addition of phosphorus oxychloride is completed, the above temperature may be maintained for an additional 30 minutes to 2 hours to complete the reaction. After the reaction is completed, it is usually left to cool and then poured into ice water to remove the precipitated crystals. If necessary, recrystallization is performed in a suitable solvent such as benzene, acetonitrile, etc. to obtain the desired sulfonyl chloride (2). In order to show more detailed synthetic operations, Examples and Comparative Examples are given below. Example 1 4.21 g of 3-cyano-4-(2-methoxy-5-sulfophenylhydrazone)-1-phenyl-5-pyrazolone sodium salt was suspended in a mixture of 10 ml of sulfolane and 10 ml of acetonitrile, and N,N
- 3.6 ml of dimethylacetamide was added. to this,
3.6 ml of phosphorus oxychloride was added at below 40°C. The reaction mixture was stirred at 50-55°C for 1.5 hours. After cooling,
It was poured into ice water and the precipitated crystals were collected. Yield of compound 8: 4.06 g (97%). mp.235-236℃ (decomposition). Comparative Example 1 Using the same compound as in Example 1, a reaction was carried out without sulfolane. 3-cyano-4-(2
-methoxy-5-sulfophenylhydrazono)-
1-phenyl-5-pyrazolone sodium salt 4.21
g was suspended in 40 ml of acetonitrile, followed by 3.6 ml of N,N-dimethylacetamide and then 3.6 ml of phosphorus oxychloride.
Added ml. After stirring at 50-55℃ for 1.5 hours,
When the same post-treatment as in Example 1 was carried out, Compound 8 was obtained in a yield of 3.40 g (81%). Comparing both experiments, it can be seen that the yield is significantly improved in the presence of sulfolane. Example 2 3-(N-methylsulfamoyl)-4-(2-
Methyl-4-sulfophenylhydrazono)-1-
Suspend 4.37 g of phenyl-5-pyrazolone sodium salt in a mixture of 20 ml of sulfolane and 30 ml of acetonitrile, and add N,N-dimethylacetamide.
3.6 ml was added followed by phosphorus oxychloride. The reaction mixture was stirred at 50-55°C for 1.5 hours. After cooling the reaction mixture, it was poured into ice water to collect the precipitated Compound 4. Yield 3.95g (91%). mp.217-218℃ (decomposition). Comparative Example 2 Using the same compound as in Example 2, a reaction was carried out without sulfolane. 4.37 g of 3-(N-methylsulfamoyl)-4-(2-methyl-4-sulfophenylhydrazono)-1-phenyl-5-pyrazolone sodium salt was suspended in 40 ml of acetonitrile, and N,N-dimethyl 3.6 ml of acetamide was added followed by phosphorus oxychloride. After stirring at 50 to 55°C for 1.5 hours, the same post-treatment as in Example 2 was performed to obtain Compound 4 in a yield of 3.04 g (70%). A comparison of Example 2 and Comparative Example 2 shows that the yield is significantly improved in the presence of sulfolane.
Claims (1)
を、スルホランの存在下に一般式()で表わさ
れる化合物と反応させることを特徴とする下記一
般式()で表わされるスルホニルクロリドの合
成法 ただし、Dyeは色素残基を表わし;R1は炭素数
1〜23のアルキル基を表わし;R2およびR3は同
じでも異つていてもよく、炭素数1〜24のアルキ
ル基を表わす。R1とR2;R2とR3は相互に結合し
て環を形成していてもよい。 Y は、リンまたはイオウを含む酸のアニオン
である。[Scope of Claims] 1. A sulfonyl chloride represented by the following general formula (), which is characterized by reacting a dye compound represented by the following general formula () with a compound represented by the general formula () in the presence of sulfolane. synthesis method of However, Dye represents a dye residue; R 1 represents an alkyl group having 1 to 23 carbon atoms; R 2 and R 3 may be the same or different and represent an alkyl group having 1 to 24 carbon atoms. R 1 and R 2 ; R 2 and R 3 may be bonded to each other to form a ring. Y is an anion of an acid containing phosphorus or sulfur.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP8841881A JPS57202353A (en) | 1981-06-09 | 1981-06-09 | Synthesis of sulfonyl chloride |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP8841881A JPS57202353A (en) | 1981-06-09 | 1981-06-09 | Synthesis of sulfonyl chloride |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS57202353A JPS57202353A (en) | 1982-12-11 |
JPH0136612B2 true JPH0136612B2 (en) | 1989-08-01 |
Family
ID=13942234
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP8841881A Granted JPS57202353A (en) | 1981-06-09 | 1981-06-09 | Synthesis of sulfonyl chloride |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS57202353A (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3199486B2 (en) * | 1992-06-30 | 2001-08-20 | ティーディーケイ株式会社 | Optical recording disc |
DE19937328B4 (en) * | 1998-08-11 | 2016-09-22 | Gottlieb Binder Gmbh & Co | Use of reactive dyes |
DE19964296B4 (en) * | 1998-08-11 | 2007-08-30 | Gottlieb Binder Gmbh & Co | New dyes used for dying e.g. wool, silk, polyamide or cotton are azo, anthraquinone, quinizarin, coumarin or indigo dyes with sulfonyl, e.g. sulfonyl chloride, or sulfonamide group(s) |
-
1981
- 1981-06-09 JP JP8841881A patent/JPS57202353A/en active Granted
Also Published As
Publication number | Publication date |
---|---|
JPS57202353A (en) | 1982-12-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2007153906A (en) | Process for the sulfinylation of heterocyclic compound | |
JPH05140080A (en) | Phenyl sulfonamide derivative | |
JPS59227870A (en) | Novel 2-guanidinothiazoline derivative and its preparation | |
KR100947402B1 (en) | Method for Producing 2-Halogen-Pyridine-Carboxylic Acid Amides | |
JPH08319272A (en) | Production of 1-haloaryl heterocyclic compound for agricultural chemical | |
EP1331222A1 (en) | Environment friendly reagents and process for halogenoalkylsulfinylation of organic compounds | |
JPH0136612B2 (en) | ||
JP4516968B2 (en) | Ortho-substituted pentafluoridesulfanyl-benzene, its preparation and its use in the form of useful synthetic intermediate steps | |
JPH04225939A (en) | Process for producing aromatic amine | |
JPH01132565A (en) | Production of popenic acid derivative | |
RU2141940C1 (en) | Method of preparing acid chlorides | |
JPS5933275A (en) | Manufacture of substituted thiadiazolyloxyacetamide | |
JP4174093B2 (en) | Method for producing triazole derivative halogen compound | |
JPH0813759B2 (en) | Method for producing alkoxybenzene derivative | |
JPH0128742B2 (en) | ||
JP4159022B2 (en) | Preparation of diazonaphthoquinonesulfonyl chloride using diphosgene and triphosgene. | |
JP2578217B2 (en) | Method for producing amidophenols | |
PT852224E (en) | ARM INTERMEDIATES FOR THE PREPARATION OF SULFAMOIL UREIA HERBICIDES AND PROCESS FOR THEIR PREPARATION | |
JP4211081B2 (en) | 4-cyanopyridazin-3-one derivatives | |
JP3942686B2 (en) | α- (Acylimino) -benzylsulfoxide or α- (acylimino) -benzylsulfones | |
JP3799580B2 (en) | Process for producing N-substituted-N-sulfonylamides | |
JP2002326989A (en) | Method for producing phthalisoimide derivative | |
JPH04139170A (en) | Substituted pyridinesufonylcarbamate-based compound, its production and production of substituted pyridinesulfonamide-based compound | |
JP3937586B2 (en) | Process for producing 1,4-bis (organosulfonyloxy) -2,3-butanediol | |
JPH0759549B2 (en) | Method for producing benzenesulfonamide |